![]() |
Ôç·¢»òÍí·¢µÄ¸ÐȾÐÔÐݿ˵IJîÒì
Oscar Roman-Marchant, MD; Carlos E. A. Orellana-Jimenez, MD; Daniel De Backer, MD, PhD; Christian Melot, MD, PhD, MSciBiostat; and Jean-Louis Vincent, MD, PhD, FCCP
Ä¿µÄ¡¡È·¶¨ICU»¼ÕßÖÐÔç·¢ºÍÍí·¢µÄ¸ÐȾÐÔÐݿ˷¢²¡ÂʺÍËÀÍöÂʵIJîÒì¡£
Éè¼Æ¡¡²É¼¯ÏµÍ³×ÊÁÏ¡£
µØµã¡¡´óѧ¸½ÊôÒ½ÔºÄÚÍâ¿Æ»ìºÏICU£¬31ÕÅ´²Î»¡£
¶ÔÏó¡¡1999Äê2Ô£2000Äê4ÔÂÆÚ¼äÊÕסICUºó³öÏÖ¸ÐȾÐÔÐݿ˵ÄËùÓл¼Õߣ¬¹²65ÈË¡£
¸ÉÔ¤¡¡ÎÞ¡£
¼ì²âºÍ½á¹û¡¡65Ãû»¼ÕßÖÐÓÐ41ÃûÔÚÊÕסICUºóµÄ24 hÄÚ³öÏÖ¸ÐȾÐÔÐÝ¿Ë (Ôç·¢¸ÐȾÐÔÐݿˣ¬ESS)£¬ÁíÍâ21Ãû»¼ÕßÔÚÊÕסICUºóµÄ24 hºó³öÏÖ¸ÐȾÐÔÐÝ¿Ë (Íí·¢¸ÐȾÐÔÐÝ¿Ë, LSS)¡£11Ãû»¼Õß³öÏÖµÚ¶þ´Î¸ÐȾÐÔÐÝ¿Ë (ESS×é7ÈË, LSS×é4ÈË); ÔÚLSS×éÓÐ1È˳öÏÖµÚÈý´Î¸ÐȾÐÔÐݿˡ£ESS×黼Õß½ÏLSS×黼ÕßÔÚÈëICUʱ¼±ÐÔÉúÀíºÍÂýÐÔ½¡¿µ×´¿öÆÀ·Ö (APACHE) II·ÖÖµ½Ï¸ß (26¡À6¶Ô20¡À6£»P = 0.002)£¬ÏµÁÐÆ÷¹ÙË¥½ßÆÀ¹À (SOFA) ·ÖÖµÒ²½Ï¸ß (11¡À3¶Ô7¡À3£»P < 0.001)£¬²¢ÇÒÆäÔÚÐݿ˷¢ÉúʱÈéËáÑÎѪŨ¶È½Ï¸ß£¬ÆäÖÐλÊý·Ö±ðΪ3.70 mmol/L [ËÄ·Öλ¼äÆÚ (2.6 ~ 6.6) mmol/L] ºÍ2.50 mmol/L [ËÄ·Öλ¼äÆÚ (1.8 ~ 4.0) mmol/L]£¬P = 0.03¡£È»¶ø£¬¸ÐȾÐÔÐݿ˳ÖÐøÊ±¼ä£¬ÖÐλÊý·Ö±ðΪ42 h [ËÄ·Öλ¼äÆÚ (21 ~ 97) h] ºÍ93 h [ËÄ·Öλ¼äÆÚ (32 ~ 241) h (P = 0.058); ¸ÐȾÐÔÐݿ˷¢ÉúºóÔÚICUµÄסԺʱ¼ä£¬ÖÐλÊý·Ö±ðΪƽ¾ù75 h [ËÄ·Öλ¼äÆÚ (38 ~ 203) hºÍ321 h [ËÄ·Öλ¼äÆÚ (96 ~ 438) h] (P = 0.018)¡£ESS×黼Õß¾ù¶ÌÓÚLSS×黼Õß¡£ESS×éµÄICUËÀÍöÂÊΪ63% (26Àý)£¬LSS×éΪ88% (21Àý) (P = 0.071)¡£ÔÚµÚÒ»´ÎÐݿ˷¢Éúʱ£¬ESS×黼Õß½ÏLSS×黼ÕßµÄSOFAÆÀ·Ö·ÖÖµ¸ß [(11¡À3) ¶Ô (9¡À3)£¬P = 0.045]£¬pHÖµµÍ [(7.24¡À0.15) ¶Ô (7.33¡À0.12)£¬P = 0.01]£¬²¢Ó¦ÓÃÁ˽ϴó¼ÁÁ¿µÄ¶à°Í°·ÖÎÁÆ£¬ÖÐλÊý·Ö±ðΪ20 mg/(kg·min) [ËÄ·Öλ¼äÆÚ (14 ~ 20) mg/(kg·min)] ºÍ12 mg/(kg·min) [ËÄ·Öλ¼äÆÚ (8 ~ 20) mg/(kg·min)] (P = 0.028)¡£
½áÂÛ¡¡Ôç·¢µÄ¸ÐȾÐÔÐݿ˲¡Çé¸üΪÑÏÖØ£¬·´Ó³Îª¸üÑÏÖØµÄÔàÆ÷¹¦ÄÜÕϰºÍÈéËáÐÔËáÖж¾£¬Í¬Ê± ÐèÒªÓ¦Óøü¶àµÄѪ¹ÜÊÕËõÒ©ÎïÖÎÁÆ£¬µ«ÊÇÔ¤ºó½ÏºÃ£¬±íÏÖΪÐݿ˳ÖÐøÊ±¼ä½Ï¶Ì¡¢ICUסԺÌì Êý½Ï¶ÌºÍËÀÍöÂÊÉԵ͡£ÒÔÉÏÇø±ð¿ÉÄÜÓ°Ïìŧ¶¾ÑªÖ¢ÖÎÁÆÒ©ÎïµÄÁÙ´²ÊÔÑ飬²¢ÇÒÔÚ·ÖÎö½á¹ûʱӦ µ±½«ÕâЩÒòËØ¿¼ÂǽøÈ¥¡£
¹Ø¼ü´Ê¡¡ÑªÈéËáÑÎ (blood lactate); סԺʱ¼ä (length of stays); Æ÷¹ÙË¥½ß (organ failure); Ô¤ºó (outcome)
¸ÐȾÐÔÐÝ¿ËÊÇICU»¼Õß³£¼ûµÄÒ»¸ö¼²²¡¹ý³Ì£¬ÔÚÊÀ½ç·¶Î§ÄÚΪµ¼Ö¼²²¡ºÍËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò» [1~3]¡£Êµ¼ÊÉϾ¡¹ÜÖ§³ÖÁÆ·¨²»¶Ï½ø²½£¬µ«¸ÐȾÐÔÐݿ˻¼ÕßµÄÔ¤ºó¼¸ºõûÓжà´ó¸ÄÉÆ[4]¡£ÖØÒªµÄÊÇÐÝ¿ËÕâÒ»Ö¸±ê¿ÉÒÔ¶ÀÁ¢µØÔ¤²âËÀÍöÂÊ[5]£¬Í¬Ê±¿ìËÙÕï¶ÏºÍÓÐЧµØÔçÆÚ¸ÉÔ¤¿ÉÓ°ÏìÐݿ˵ĽøÕ¹ºÍËÀÍöÂÊ[6]¡£
LundbergµÈ[7] ±¨µÀ£¬ICUÄڵϼÕß·¢Éú¸ÐȾÐÔÐÝ¿Ë½ÏÆÕͨ²¡·¿»¼Õß·¢Éú¸ÐȾÐÔÐݿ˵ÄËÀÍöÂʵ͡£ ÕâЩ×÷Õß[7] Ìá³ö£¬Òѹ۲쵽µÄ²»Í¬ËÀÍöÂÊ¿ÉÄÜÊÇÓÉÓÚICU»¼Õߵõ½ÔçÆÚÖÎÁƸÉÔ¤µÄ½á¹û¡£¶øÒÑ´æÔÚ¶àÆ÷¹Ù¹¦ÄÜË¥½ßµÄICU»¼Õß³öÏÖ¸ÐȾÐÔÐݿ˵ÄÔ¤ºóºÜ²î£¬Ñª¹ÜÊÕËõÒ©ÎïÖÎÁÆ¿ÉÄÜÎÞЧ [8]; ËùÒÔ¸ÐȾÐÔÐݿ˵ķ¢Éúʱ¼äÔÚ¾ö¶¨Ô¤ºó·½Ãæ·Ç³£ÖØÒª£¬µ«ÁÙ´²ÊÔÑéͨ³£Î´Ìṩ´Ë·½ÃæµÄ×ÊÁÏ¡£±¾Ñо¿µÄÄ¿µÄÔÚÓÚÆÀ¼ÛICUÄÚÔç·¢ºÍÍí·¢µÄ¸ÐȾÐÔÐݿ˵ÄÁ÷Ðв¡Ñ§ºÍÔ¤ºó¡£
»¼ Õß ºÍ ·½ ·¨
ÓÉÓÚ±¾ÊÔÑéΪ¹Û²ìÐÔÊÔÑ飬Â×ÀíίԱ»áÃâ³ýÁËÇ©ÊðÖªÇéͬÒâÊéÕâÒ»ÐèÒª¡£ÎÒÃǻعËÐԵطÖÎöÁËÔÚ 14 mo (1999Äê2Ô£2000Äê4ÔÂ) µÄʱ¶ÎÄÚËùÓÐÊÕס֢֨¼à»¤²¡·¿ (ÓµÓÐ31ÕÅ´²Î») µÄ¸ÐȾÐÔÐݿ˻¼ÕßµÄÁÙ´²×ÊÁÏ£¬°üÀ¨ÁÙ´²¡¢ÑªÒº¶¯Á¦Ñ§ºÍÉúÎïѧ×Ê ÁÏ¡£¸ÐȾÐÔÐݿ˶¨ÒåΪÔÚÓÐÈ·Ôä¸ÐȾ´æÔÚʱ£¬¾¡¹Ü¾¹ýÊäÒºÀ©ÈÝÈÔ·¢Éú³ÖÐøÖÁÉÙ1 hµÄµÍѪѹ (ÊÕËõѹ < 90 mmH£¬»òÊÕËõѹ´Ó»ùÏßֵϽµ > 40 mmHg)£¬ÐèҪʹÓÃѪ¹ÜÊÕËõҩʹÊÕËõѹά³ÖÔÚ90 mmHgÒÔÉÏ£¬Í¬Ê±°éÓÐÆ÷¹Ù¹¦ÄÜÕϰ»òµÍ¹à×¢µÄ±íÏÖ [°üÀ¨ (µ«²»¾ÖÏÞÓÚ) ÈéËáÐÔËáÖж¾¡¢ÉÙÄò»ò¼±ÐÔ¾«Éñ״̬µÄ¸Ä±ä] (ÓÉÃÀ¹ú¼²²¡Ô¤·ÀºÍ¿ØÖÆÖÐÐ͍Òå[9])¡£
ÔÚÎÒÃÇÒ½Ôº£¬Ñ»·Ðݿ˵ÄÖÎÁÆ×ñÑÒ»Ïî±ê×¼·½°¸¡£¸´ËÕÊÇÔÚÒºÌåÖÎÁƵĻù´¡ÉϽøÐеģ¬×î³õʹÓà ½ºÌåÒºÒÔ»Ö¸´Õý³£µÄѪѻ·ÈÝÁ¿¡£´ËÍ⣬¾¹ýÒºÌåÖÎÁƺóÈÔÄÑÒÔ¿ØÖƵĵÍѪѹʱ£¬²ÉÓöà°Í°· [¸ß´ï20 mg/(kg·min)] ÖÎÁÆ¡£µ±¶à°Í°·ÁÆÐ§²»ÂúÒâʱ£¬Ê¹ÓÃÈ¥¼×ÉöÉÏÏÙËØ£¬ÒÔά³Öƽ¾ù¶¯ÂöѹÔÚ65 ~ 75 mmHgÖ®¼ä¡£µ±ÐÄÔàÖ¸Êý < 2.5 L/(min·m2)ºÍ (»ò) »ìºÏ¾²ÂöѪÑõ±¥ºÍ¶È < 60%£¬»ò³¬ÉùÐĶ¯Í¼Õï¶ÏÎªÖØ¶ÈÐļ¡ÒÖÖÆÊ±£¬¼ÓÓöà°Í·Ó¶¡°·£¬¼ÁÁ¿¿É´ï20 mg/(kg·min)¡£Èç¹ûÓ¦ÓÃÉÏÊöÒ©ÎïºóѪÁ÷¶¯Á¦Ñ§ÈÔ²»Îȶ¨£¬Ôò¼ÓÓà ÉöÉÏÏÙËØ¡£ËùÓÐÐèҪѪ¹ÜÊÕËõÒ©ÎïÖÎÁƵϼÕß¾ù·ÅÖ÷ζ¯Âöµ¼¹Ü¡£¾¡ÔçÍ£ÓÃÉöÉÏÏÙËØÄÜÒ©Îï¡£¸ù¾Ý³ä ӯѹ·´¸´Ìí¼ÓÊä×¢ÒºÌåÒÔ±ÜÃâµÍѪÈÝÁ¿µÄ·¢Éú¡£¸ù¾Ýŧ¶¾ÑªÖ¢¿ÉÄܵįðÔ´ÍÆ²â²¡Ôѧ£¬½øÐйãÆ×¿¹Éú ËØµÄ¾ÑéÐÔÖÎÁÆ£¬²¢¸ù¾ÝÅàÑø½á¹û¼°Ê±½øÐе÷Õû¡£
¾¹ýÊä×¢¾§ÌåºÍ (»ò) ½ºÌåÈÜÒººóÓ¦ÓÃѪ¹ÜÊÕËõÒ©Îï (¶à°Í°·¡¢È¥¼×ÉöÉÏÏÙËØ»òÉöÉÏÏÙËØ) ÖÎÁƺóÈç¹ûÐÄÔàÖ¸ÊýûÓÐÔö¼Ó£¬Í¬Ê±·Î¶¯ÂöШѹά³ÖÔÚ10 ~ 18 mmHgÖ®¼äʱӦ¿¼ÂÇ·¢ÉúÁ˸ÐȾÐÔÐݿˡ£¶ÔÓÚµÍѪÈÝÁ¿»òÐÄÔ´ÐÔÐݿ˺óÀ´·¢Éúŧ¶¾ÑªÖ¢Õߣ¬ÓÉÓÚºÜ ÄÑÈ·¶¨Å§¶¾ÑªÖ¢µ¼ÖÂÐݿ˵ÄÈ·ÇÐÆðʼʱ¼ä¶øÓèÒÔÌÞ³ý¡£
ÈëסICU 24 hÄÚ·¢ÉúµÄ¸ÐȾÐÔÐÝ¿ËΪÔç·¢ÐÔ [Ôç·¢¸ÐȾÐÔÐÝ¿Ë (early septic shock, ESS)]£¬ÈëסICU ºó24 hÒÔºó·¢ÉúÕßµÄΪÍí·¢ÐÔ [Íí·¢¸ÐȾÐÔÐÝ¿Ë (late septic shock, LSS)]¡£ÔÚ±¾Ñо¿ÖУ¬¸ÐȾÐÔÐݿ˻º½âÊÇָֹͣʹÓÃѪ¹ÜÊÕËõÒ©ÎïÖÁÉÙ48 h¡£³¬¹ý48 hÒÔºóÓÖÐèÖØÐÂʹÓÃѪ¹ÜÊÕËõÒ©ÎïÕßΪеĸÐȾÐÔÐݿ˷¢Éú¡£¶ÔÁ½¸ö×éµÄµÚÒ»´Î·¢ÉúµÄÐݿ˽øÐзֱð·ÖÎö£¬ ESS×éºóÀ´·¢ÉúµÄËùÓÐÐݿ˾ù×÷ΪLSS×éµÄ×ÊÁÏÓèÒÔ·ÖÎö¡£
ÊÕ¼¯ÒÔÏÂ×ÊÁÏ£ºÌåΡ¢Æ½¾ù¶¯Âöѹ¡¢ÐÄÂÊ¡¢ºôÎüƵÂÊ (·Ç»úÐµÍ¨Æø»ò»úÐµÍ¨ÆøµÄºôÎüƵÂÊ)¡¢ÑõºÏÇé¿ö (·ÎÅÝ-¶¯ÂöÑõ·Öѹ²î»ò·Î¶¯ÂöÑõ·Öѹ¡¢ÎüÈëÑõŨ¶È¡¢¶¯ÂöѪpHÖµ)¡¢ÑªÇåÄÆ¡¢¼Ø¡¢¼¡ôû¡¢Ñª ϸ°û±ÈÈÝ¡¢°×ϸ°û¼ÆÊý¡¢Glasgow»èÃÔÆÀ·Ö¡¢Ñª¹ÜÊÕËõÒ©Îï¼ÁÁ¿ (¶à°Í°·¡¢È¥¼×ÉöÉÏÏÙËØ»òÉöÉÏÏÙËØ)¡¢ÑªÐ¡°å¼ÆÊý¡¢µ¨ºìËØºÍѪÈéËáÑÎŨ¶È¡£Èç¹ûÓе¥¸ö Êý¾ÝÒÅ©£¬Ôò²ÉÓøÃȱʧÊý¾ÝǰºóµÄÏàÁÚÊý¾ÝµÄƽ¾ùÖµÌæ´ú£»µ±ÓÐÁ¬ÐøÊý¾ÝÒÅ©ʱ£¬ÔòÔÚ·ÖÎöʱ¶¨Îª Êý¾Ýȱʧ¡£
ËùÓл¼ÕßÔÚÒ»½øÈëICUʱ±ã½øÐÐAPACHE(acute physiology and chronic health evaluation) IIÆÀ·Ö[10] ºÍSOFA(sequential organ failure assessment) ÆÀ·Ö[11]¡£LSS×éµÄ»¼ÕßÔÚ·¢Éú¸ÐȾÐÔÐݿ˵ĵ±ÌìÔÙ×÷SOFAÆÀ ·Ö¡£ÔÚ½øÈëICUʱ¶ÔÒÔÏÂŧ¶¾ÑªÖ¢µÄΣÏÕÒòËØÓèÒԼǼ£ºÍâÉ˵ÄÕï¶Ï¡¢ÊÖÊõ (ÔñÆÚ»ò¼±Õï)¡¢»úÐµÍ¨Æø¡¢Éñ¾Ñª¹Ü¼²²¡²¡Ê·¡¢ÃâÒßÒÖÖÆ¡¢Ö×Áö»ò¸ÎÓ² »¯¡£Í³¼ÆÑ§·ÖÎö²ÉÓÃt ¼ìÑé¡¢c2¼ìÑéºÍFisher¾«È·¼ìÑé¡£·Ç²ÎÊý±äÁ¿²ÉÓÃMann-WhitneyéóºÍ¼ìÑé·Ö Îö¡£³ý·ÇÌØÊâ±ê×¢£¬Êý¾Ý¾ù²ÉÓÃx£ ± s±íʾ¡£P < 0.05±íʾÓÐͳ¼ÆÑ§ÒâÒå¡£
½á¡¡¡¡¹û
ÔÚ41ÃûESS»¼ÕߺÍ24ÃûLSS»¼ÕßÖ®¼ä£¬Ô·¢¼²²¡¡¢Î£ÏÕÒòËØºÍÔ·¢¸ÐȾÔîûÓвîÒì (±í1¡¢2)¡£Ðݿ˷¢ÉúʱËùÓл¼Õß¶¼°´ÕÕǰÎÄÐðÊöµÄ±ê×¼·½°¸¸øÓè»ý¼«µÄ²¹ÒººÍѪ¹Ü»îÐÔÒ©ÎïÖÎÁÆ¡£ËùÓл¼Õ߸øÓè¾ÑéÐÔ¿¹ÉúËØÖÎÁƲ¢¸ù¾ÝÅàÑø½á¹û½øÐе÷Õû¡£¾ÑéÐÔ ¿¹ÉúËØÖÎÁƵÄ׼ȷÂÊÔÚÁ½×éÖÐÀàËÆ (Êý¾ÝδÏÔʾ)¡£ÔÚESS×飬ÈëסICUµÄµ±Ê±»òÒÔºóµÄ6 hÄÚÓÐ35Ãû»¼Õß·¢ÉúÐݿˣ¬6 ~ 12 h 2Ãû£¬12 ~ 24 h 4Ãû£»ÔÚLSS×飬ÈëICU 24 ~ 48 hÓÐ9Ãû»¼Õß³öÏÖÐݿˣ¬48 ~ 120 h 6Ãû£¬> 120 h 9Ãû¡£ÓëÎÒÃÇÔ¤ÁϵĽá¹ûÒ»Ö£¬ÈëסICUµ±Ê±µÄAPACHE IIÆÀ·ÖESS×é¸ßÓÚLSS×é (P = 0.002)¡£LSS×éÔÚICU×ܵÄסԺÌìÊýºÍÐݿ˳öÏÖºóÔÚICUסԺÌìÊý³¤ÓÚESS×é (P < 0.001)(±í1)¡£ESS×éÖУ¬15Ãû´æ»îÕߺÍ21ÃûËÀÍöÕß½ÓÊÜÁË»úеͨ ÆøÖÎÁÆ£»LSS×éÖУ¬7Ãû´æ»îÕߺÍ16ÃûËÀÍöÕß½ÓÊÜÁË»úÐµÍ¨ÆøÖÎÁÆ¡£ESS×黼ÕßµÚÒ»´ÎÐݿ˵ÄËÀÍöÂÊ Îª51% (21/41)£¬LSS×éΪ71% (17/24)(P = 0.07)¡£11Ãû»¼Õß·¢ÉúµÚ¶þ´ÎÐݿˣ¬1Ãû»¼Õß·¢ÉúµÚÈý´ÎÐݿˡ£ÕâЩ»¼ÕßµÄËÀÍöÂÊΪ82% (9/11£»Í¼1)¡£
±í3 ÁоÙÁË»¼Õ߸ÐȾÐÔÐݿ˵ÄÇé¿ö¡£µÚÒ»´ÎÐݿ˷¢Éúʱ£¬ESS×黼Õß½ÏLSS×黼ÕßSOFAÆÀ·Ö¸ß£¬ pHµÍ£¬ÑªÈéËáÑÎŨ¶È¸ß£¬¶à°Í°·Ê¹ÓüÁÁ¿´ó¡£µ«ÊÇ£¬µ±×ۺϿ¼ÂÇËùÓиÐȾÐÔÐÝ¿Ëʼþʱ£¬ÔÚ¸ÐȾÐÔ Ðݿ˷¢Éúµ±ÌìESS×éºÍLSS×éSOFAÆÀ·ÖûÓÐÏÔÖø²îÒì (P = 0.209); ÔÚÈëסICUµÄµ±Ê±ºÍÐݿ˷¢Éúµ±ÈÕ£¬ESS×黼ÕßµÄÐÄѪ¹ÜSOFAÆÀ·Ö¸ßÓÚLSS×黼Õß (Êý¾ÝδÏÔʾ); ÔÚÈëסICUµÄµ±Ê±£¬ESS×黼ÕßµÄÉöÔàSOFAÆÀ·Ö¸ßÓÚLSS×黼Õß (P = 0.011); Ðݿ˷¢Éúʱ£¬ESS×黼ÕßµÄѪÈéËáÑÎˮƽ¸ßÓÚLSS×éµÄ»¼Õß (P = 0.03)¡£
ÌÖ¡¡¡¡ÂÛ
¸ÐȾÐÔÐÝ¿ËÊÇŧ¶¾ÑªÖ¢×îÑÏÖØµÄÀàÐÍ£¬ËÀÍöÂÊºÜ¸ß [4]£¬¶àÊýϵÓÉÓÚ¶à¸öÆ÷¹Ùϵͳ½øÐÐÐÔ¹¦ÄÜÕϰ¶ø·¢Õ¹Îª¶àÆ÷¹Ù¹¦ÄÜË¥½ßËùÖ [2,12,13]¡£ÎÒÃǵÄÑо¿ÏÔʾ£¬ËÀÍöÂÊΪ63% (ESS) ºÍ88% (LSS)£¬¸ßÓÚ½üÆÚ±¨µÀµÄÄÇЩÁÙ´²ÊÔÑé½á¹û[14] ¡£Õâ¿ÉÄÜÊÇÓÉÓÚ»¼ÕßÖÐÓкܶಡÀý»¼ÓÐÑÏÖØµÄ»ù´¡¼²²¡ (ÈçÍíÆÚ¶ñÐÔÖ×Áö¡¢¸ÎÓ²»¯ºÍÉñ¾ÏµÍ³¼²²¡)£¬ÕâЩ»¼Õßͨ³£ÔÚÆäËûÑо¿ ÖÐÊDZ»ÌÞ³ýµÄ¡£ÓÐÒâÒåµÄÊÇ£¬½üÆÚÔÚÅ·ÖÞ½øÐеÄÁ÷Ðв¡Ñ§Ñо¿ [15,16] ±¨µÀÁËÀàËÆµÄ¸ÐȾÐÔÐݿ˵IJ¡ËÀÂÊΪ60%¡£ÕâÌáʾÓÉÓÚÅųýÁËÒ»Ð©ÌØÊâµÄÖØÖ¢¼à»¤»¼ Õߣ¬ÐµÄÖÎÁÆÒ©ÎïÁÙ´²ÊµÑéËù±¨µÀµÄËÀÍöÂʺÍʵ¼ÊÇé¿ö´æÔÚ²îÒì¡£
ÖÎÁÆ¿ªÊ¼µÄʱ¼ä¶Ô֢֨ŧ¶¾ÑªÖ¢ºÍ¸ÐȾÐÔÐݿ˻¼ÕßµÄÔ¤ºóÓÐÖØÒªÓ°Ïì¡£ÔçÆÚºÍÓÐЧµÄ¿¹ÉúËØÖÎÁÆ¿É ÒÔ½µµÍËÀÍöÂÊ[3,17]¡£LundbergµÈ[7] ±¨µÀ£¬ÔÚÆÕͨ²¡·¿·¢Éú¸ÐȾÐÔÐݿ˵ϼÕߣ¬¾¡¹ÜÄêÁä½ÏÇá²¢ÇÒ APACHEÆÀ·ÖµÍ£¬µ«ÆäÏà¶ÔÓÚÔÚICUÄÚ·¢Éú¸ÐȾÐÔÐݿ˵ϼÕßµÄËÀÍöÂÊÓÐÔö¸ßµÄÇ÷ÊÆ¡£ÕâЩ×÷Õß [7] ÈÏΪ£¬ÆÕͨ²¡·¿±ÈICU½Ï³ÙʹÓÃѪ¹ÜÊÕËõÒ©ÓëËÀÍöÂʸßÓйء£È»¶ø£¬¶ÔÒѾ³öÏÖÑÏÖØÆ÷¹Ù¹¦ÄÜÕϰµÄ»¼ Õߣ¬¼´Ê¹Ó¦ÓÃǿѪ¹ÜÊÕËõÒ©ÎïЧ¹ûÒ²¿ÉÄܲ»ÀíÏë¡£AbidµÈ [8] ±¨µÀËÀÍöÂÊÓëÆ÷¹Ù¹¦ÄÜÕϰµÄ³Ì¶ÈºÍ¿ªÊ¼Ó¦ÓÃÈ¥¼×ÉöÉÏÏÙËØÇ°ÔÚICUסԺµÄʱ¼ä³¤¶ÌÓйء£
ÎÒÃǵÄÑо¿ÏÔʾÁËÔç·¢ºÍÍí·¢µÄ¸ÐȾÐÔÐݿ˵ÄÖØÒª²îÒì¡£ÔÚÈëסICUºóÔç·¢µÄ¸ÐȾÐÔÐݿ˽ÏÍí·¢Õß ÑÏÖØ£¬ESS»¼ÕßµÄAPACHE IIºÍSOFAÆÀ·Ö¾ù¸ßÓÚLSS»¼Õߣ¬ÌáʾÕâЩ»¼Õߵļ²²¡ºÍÆ÷¹Ù¹¦ÄÜÕϰ¸ü ΪÑÏÖØ¡£È»¶ø£¬ÔÚICUÖÐESS»¼ÕßÐݿ˳öÏÖºóµÄסԺʱ¼ä½ÏLSS»¼Õß¶Ì£¬¶øÍí·¢Ðݿ˻¼ÕßµÄËÀÍöÂÊ±È Ôç·¢ÐÝ¿ËÒ²Òª¸ßһЩ£»Òò´Ë£¬ESS»¼Õß²¡ÇéËÆºõ¸üÑÏÖØ£¬µ«Ô¤ºó·´¶ø½ÏºÃ¡£KnausµÈ [18] Ò²×¢Òâµ½ÁËÈç¹ûŧ¶¾×ÛºÏÕ÷»¼Õߵġ°Òýµ¼Ê±¼ä¡±³¤£¬¼´È·Õïŧ¶¾ ×ÛºÏÕ÷ǰסԺ»òסICUµÄʱ¼ä³¤£¬ÔòÆäËÀÍöÂÊÔö¸ß¡£È»¶ø£¬Brun-BuissonµÈ [12] ·¢ÏÖ£¬ËÀÍöÂÊÓëÈëסICUºóµ½·¢Éú֢֨ŧ¶¾ÑªÖ¢µÄ¼ä¸ôʱ¼äÎ޹ء£Õâ Щ²»Í¬µÄ½á¹û£¬¿ÉÄÜÊÇÑо¿ÖвÉÓÃÁ˲»Í¬µÄŧ¶¾ÑªÖ¢¶¨ÒåËùÖ¡£
ÔÚÎÒÃǵ¥Î»£¬ËùÓиÐȾÐÔÐݿ˻¼ÕßµÄÖÎÁƶ¼×ñÑÒ»ÏîÑϸñµÄ·½°¸£¬¹ÊסԺʱ¼ä³¤¶Ì¼°Ô¤ºóÓëÖÎÁÆ ·½·¨µÄ²îÒìÎ޹ء£ÖØÒªµÄÊǾ¡¹Ü¸ÐȾµÄ²¡ÔÌåÓÐËù²»Í¬£¬µ«Ôç·¢ºÍÍí·¢¸ÐȾÐÔÐݿ˵ÄΣÏÕÒòËØ»ò¸ÐȾ À´Ô´Ö®¼ä²¢ÎÞ²îÒì¡£ÔÚÍí·¢×飬¼Ùµ¥°û¾úËùÖµĸÐȾ½ÏΪ³£¼û£¬Õâ¿ÉÄܲ¢²»Ææ¹Ö£¬ÒòΪÔÚICUסԺʱ ¼ä³¤µÄ»¼Õߺϲ¢Ò½ÔºÄÚ¸ÐȾ¸üΪ³£¼û¡£ESS×éÖ÷ÒªµÄ²¡ÔÌåΪ·ÎÑ×Á´Çò¾ú¡£ÓÉÓÚ¼Ùµ¥°û¾ú¸ÐȾÓë¸ßËÀ ÍöÂÊÏà¹Ø£¬Òò´Ë²¡Ô΢ÉúÎïµÄ²»Í¬¿ÉÒÔ²¿·Ö½âÊÍËÀÍöÂʵIJîÒì [19]¡£ÁíÍâÒ»¸ö¶ÔÕâЩ¹Û²ì½á¹ûµÄ¿ÉÄܽâÊÍÊÇ£¬Ñª¹ÜÊÕËõÒ©ÎïÔÚ»·Á×ËáÏÙÜÕ´úлÖеÄ×÷Ó㬠Æä¿ÉÒÔͨ¹ýÉöÉÏÏÙËØÄÜÊÜÌåµ÷½ÚÑ×Ö¢·´Ó¦[20,21] ¡£
×ÜÖ®£¬¾¡¹ÜΣÏÕÒòËØ¡¢ÈëסICUʱµÄ»ù´¡¼²²¡ºÍ¸ÐȾÀ´Ô´ÏàËÆ£¬ÈëICUºóÔç·¢µÄ¸ÐȾÐÔÐݿ˻¼Õß ²¡Çé¸üÑÏÖØ£¬Æ÷¹Ù¹¦ÄÜÕϰ¸üÖØ£¬µ«Ô¤ºó½ÏºÃ¡£ÕâЩ²îÒì¿ÉÄÜÓ°ÏìÁÙ´²ÊÔÑéµÄ½á¹û£¬ÔÚ·ÖÎöÁÙ´²ÊÔÑé ½á¹ûʱӦ½«ÕâЩÒòËØ¿¼ÂǽøÈ¥¡£
(ÉòÄþ Ò룻ºØÝí У)
²Î ¿¼ ÎÄ Ï×
1 Parrillo JE, et al. Ann Intern Med 1990; 113:227-242
2 Ruokonen E, et al. Crit Care Med 1991; 19:1146-1151
3 Leibovici L, et al. Scand J Infect Dis 1997; 29:71-75
4 Friedman G, et al. Crit Care Med 1998; 26:2078-2086
5 Rello J, et al. Intensive Care Med 1994; 20:94-98
6 Balk RA. Crit Care Med 1998; 26:983-984
7 Lundberg JS, et al. Crit Care Med 1998; 26:1020-1024
8 Abid O, et al. Crit Care Med 2000; 28:947-949
9 Garner JS, et al. Am J Infect Control 1988;16:128-140
10 Knaus WA, et al. Crit Care Med 1985;13:818-829
11 Vincent JL, et al. Crit Care Med 1998; 26:1793-1800
12 Brun-Buisson C, et al. JAMA 1995; 274:968-974
13 Russell JA, et al. Crit Care Med 2000; 28:3405-3411
14 Bernard GR, et al. N Engl J Med 2001; 344:699-709
15 Annane D, et al. Am J Respir Crit Care Med 2003; 168:165-172
16 Alberti C, et al. Am J Respir Crit Care Med 2003; 168:77-84
17 Leibovici L, et al. J Intern Med 1998; 244:379-386
18 Knaus WA, et al. JAMA 1993; 270:1233-1241
19 Fagon JY, et al. Am J Med 1993; 94:281-288
20 Uusaro A, et al. Intensive Care Med 2000; 26:299-304
21 Ronco JJ. Crit Care Med 2001; 29:1837-1838
¡¾Ó¢ÎÄÔ¼þÇë²ÎÔÄ CHEST 2004; 126: 173-178¡¿